A landscape of response to drug combinations in non-small cell lung cancer
Combination of anti-cancer drugs is broadly seen as way to overcome the often-limited
efficacy of single agents. The design and testing of combinations are however very …
efficacy of single agents. The design and testing of combinations are however very …
Advantages of the combinatorial molecular targeted therapy of head and neck cancer—A step before anakoinosis-based personalized treatment
R Kleszcz - Cancers, 2023 - mdpi.com
Simple Summary Head and Neck Squamous Cell Carcinoma (HNSCC) is a major threat to
public health around the world. Its occurrence is linked to genetic events and environmental …
public health around the world. Its occurrence is linked to genetic events and environmental …
Therapeutic targeting of FGFR signaling in head and neck cancer
Z Wang, KS Anderson - The Cancer Journal, 2022 - journals.lww.com
Squamous cell carcinoma of the head and neck (HNSCC) is the sixth most prevalent cancer
worldwide, with an annual incidence of 600,000 new cases. Despite advances in surgery …
worldwide, with an annual incidence of 600,000 new cases. Despite advances in surgery …
Multi-kinase compensation rescues EGFR knockout in a cell line model of head and neck squamous cell carcinoma
Background Head and neck squamous cell carcinoma (HNSCC) is a debilitating disease
with poor survival rates. While the epidermal growth factor receptor (EGFR)-targeting …
with poor survival rates. While the epidermal growth factor receptor (EGFR)-targeting …